JPMorgan Chase & Co. Cuts Unum Group (NYSE:UNM) Price Target to $92.00

Unum Group (NYSE:UNM) had its price objective lowered by equities research analysts at JPMorgan Chase & Co. from $94.00 to $92.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the financial services provider’s stock. JPMorgan Chase & Co.‘s price objective suggests a potential upside of 18.50% from the company’s previous close.

Other equities analysts also recently issued research reports about the company. Wolfe Research upgraded Unum Group to a “strong-buy” rating in a research note on Tuesday, September 16th. Evercore ISI lowered their target price on Unum Group from $100.00 to $96.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. UBS Group set a $87.00 price target on Unum Group and gave the company a “neutral” rating in a research report on Wednesday, July 30th. Weiss Ratings restated a “buy (b)” rating on shares of Unum Group in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company cut their price objective on shares of Unum Group from $100.00 to $98.00 and set an “overweight” rating for the company in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $94.42.

Unum Group Stock Performance

Shares of NYSE:UNM traded up $4.71 during midday trading on Tuesday, reaching $77.64. The company had a trading volume of 820,476 shares, compared to its average volume of 1,402,761. The stock has a market cap of $13.22 billion, a P/E ratio of 9.29, a P/E/G ratio of 1.23 and a beta of 0.36. The company’s 50 day moving average price is $75.04 and its 200 day moving average price is $76.87. The company has a current ratio of 0.30, a quick ratio of 0.30 and a debt-to-equity ratio of 0.31. Unum Group has a 52-week low of $63.98 and a 52-week high of $84.48.

Unum Group (NYSE:UNM) last announced its quarterly earnings data on Monday, November 3rd. The financial services provider reported $2.09 EPS for the quarter, missing the consensus estimate of $2.15 by ($0.06). The company had revenue of $3.38 billion during the quarter, compared to the consensus estimate of $3.31 billion. Unum Group had a return on equity of 13.44% and a net margin of 11.77%.The business’s revenue was up 5.0% on a year-over-year basis. During the same period in the prior year, the firm posted $2.13 EPS. Unum Group has set its FY 2025 guidance at EPS. As a group, sell-side analysts anticipate that Unum Group will post 9.14 EPS for the current fiscal year.

Institutional Trading of Unum Group

Several institutional investors and hedge funds have recently modified their holdings of UNM. Quintet Private Bank Europe S.A. purchased a new position in shares of Unum Group during the second quarter worth about $28,000. Vermillion & White Wealth Management Group LLC purchased a new position in Unum Group in the 1st quarter worth approximately $30,000. Legacy Investment Solutions LLC purchased a new stake in shares of Unum Group during the 2nd quarter valued at $30,000. Atwood & Palmer Inc. grew its position in Unum Group by 100.0% in the second quarter. Atwood & Palmer Inc. now owns 400 shares of the financial services provider’s stock worth $32,000 after acquiring an additional 200 shares in the last quarter. Finally, N.E.W. Advisory Services LLC bought a new position in Unum Group in the first quarter valued at $35,000. Hedge funds and other institutional investors own 86.57% of the company’s stock.

About Unum Group

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.